Advanced intercross line (AIL) is a powerful tool for high-resolution mapping of quantitative trait loci (QTLs). Several AILs have been generated to refine QTLs since the method was proposed about a decade ago. However, no AIL has been used for identifying novel QTLs. Here we used an AIL to test this possibility. We genotyped 308 (DBA/1 Â FVB/N) F 11/12 AIL mice with 109 informative markers covering four chromosomes, with an average intermarker distance of 5.5 Mb. Several normally distributed quantitative traits involved in the immune response during the course of collagen-induced arthritis (CIA), such as anti-collagen II antibodies, T-cell subset proportions and reactive oxygen species (ROS) production were taken as phenotypes. Four QTLs, namely Ciaa1, Lctlp1, Lctlp2 and Rosq1, controlling anti-collagen II IgG2a levels, lymph nodes CD8 þ T cell proportion and ROS production were identified with support intervals of 15, 14, 8 and 8 Mb, respectively. Alleles of Lctlp1 and Lctlp2 suppressing CD8 þ T cell proportion as well as the Rosq1 allele enhancing ROS production were correlated with higher CIA severity scores. Taken together, we successfully used an AIL to identify novel QTLs controlling immune responses during CIA with relatively small support intervals.
Introduction
An advanced intercross line (AIL) is generated by random intercross breeding of two inbred strains for several generations, resulting in the accumulation of many recombination events and thus high genomic resolution. 1 With an appropriate AIL, the confidence intervals (CIs) of quantitative trait loci (QTLs) are expected to be t/2 times smaller than those resulting from the same-size F2 progeny, where t is the number of AIL generations. Therefore, AIL is supposed to be a powerful approach for high-resolution mapping of QTLs. Indeed, this approach was successfully applied to refine QTLs in several studies. Since the propositon of AIL in 1995, eight AIL have been generated, including five mouse lines, [2] [3] [4] [5] [6] one rat line, 7, 8 one chicken line 9 and one mosquito line. 10 All were used to refine QTLs that were originally identified in the F2 progeny with big CIs. Indeed, those QTLs were well resolved and some were of enough resolution to permit the eventual identification of candidate genes.
Theoretically, AIL could also be used for directly identifying QTLs, with the advantage of identifying the precise QTL localization and resolving closely linked QTLs. This holds especially for linked QTLs containing two alternative homozygote susceptibility genes. 1 However, up to date, no AIL has been used for the purpose of identifying QTLs directly. The main reason for this reluctance in adopting this approach being the extensive resources that AIL production, phenotyping and genotyping require. Additionally, as Darvasi and Soller 1 pointed out, AIL has lower power to detect the quantitative effect associated with a particular marker than F2.
In a recent study, we produced a less resourcedemanding AIL using 10 breeding cages in each generation and successfully used it to refine three collagen-induced arthritis (CIA), QTLs previously identified in the F2 progeny. 11, 12 In this study, in order to test the possibility of identifying QTLs directly in AIL, we genotyped 308 F11/12 AIL mice with 109 genetic markers covering four chromosomes, with an average intermarker distance of 5.5 Mb. Several normally distributed immune-response quantitative traits, such as antibodies to collagen type II and T-cell subset proportions in lymph nodes as well as reactive oxygen species (ROS) were investigated. Four QTLs with support intervals of 8-15 Mb were identified.
Results
Heterogeneity and recombination frequency in the F 11/12 (DBA/1J Â FVB/N)AIL A simulation test carried out by Darvasi and Soller 1 showed that the breeding population size used to generate AIL could affect the quality of QTL mapping, and it was suggested to use no less than 50 random breeding cages in each generation to produce AIL mice. All AIL used previously were produced in this way despite its considerable demand on resources. The AIL used in this study was generated with only 10 random intercross matings at each generation. However, it was successfully used to refine three QTLs previously identified in the F2 progeny, indicating that this AIL could be used for QTL high-resolution mapping. 11, 12 Then, we examined the heterogeneity and recombination frequencies, which are important parameters for QTL mapping accuracy. Heterogeneity was tested to investigate the allele distribution on four chromosomes and it was estimated from the percentage of DBA/1 allele of the markers used for genotyping. In AIL mice, the percentage of DBA/1 alleles of all the markers ranged from 12 to 65%, which was not as good as those of F2 mice (from 47 to 54%). Only one genomic region that is close to the centromere of chromosome 5 lost the DBA/1 homozygous genotype; however, no genome region was fixed. Recombination frequencies presented as events of recombination per 100 Mb were also calculated for the four chromosomes. The recombination frequencies in AIL ranged from 3.15 to 4.67, whereas those in F2 mice ranged from 0.87 to 1.05. The recombination frequency in AIL was approximately four times higher than that in F2 progeny, only slightly lower than the theoretically ideal value (5.5-6 times) (Figure 1 ).
Phenotype characteristics of the F 11/12 (DBA/1J Â FVB/N)AIL Table 1 summarizes the phenotype characteristics in the AIL progeny. Six quantitative traits were determined; the anti-collagen II Ab-subtypes IgG1 and IgG2a, CD4 þ and CD8 þ T cell proportions in lymph nodes as well as the ROS production in CD4 þ T cells and neutrophils. All phenotypes were normally distributed.
We observed a significant sex effect on ROS production in both CD4
þ T cells and neutrophiles, with males producing more ROS than females. A sex effect was also observed on CD8 þ T cell proportion in lymph nodes, with males having an average of 3.9% unit of CD8 þ T cells more than females.
Identification of QTLs in AIL Subsequent linkage and permutation analyses revealed four novel QTLs, located on chromosomes 2, 5 and 7. Identification of QTLs using AIL X Yu et al CIA autoantibody QTL 1 (Ciaa1) on chromosome 7 was identified as a QTL controlling the collagen II-specific IgG2a phenotype. It had a highly significant evidence of linkage to marker D7Mit193 (logarithm of the odds (LOD) score of 4.5) with a support interval of 15 Mb and the DBA/1 allele being the IgG2a-enhancing allele in a dominant manner (Figure 2a ). The second QTL, ROS production QTL 1 (Rosq1) on chromosome 7 was found to control the ROS production of neutrophiles in female mice. It showed significant evidence of linkage to the peak marker D7Mit228 (LOD score of 4.8) with a support interval of 8 Mb and the DBA/1 allele being the ROSenhancing allele in an additive manner. This QTL did not control the ROS production in CD4 þ T cells (Figure 2b ). Two QTLs controlled the CD8 þ T cells proportion in lymph nodes. Lymph node cytotoxic T lymphocyte percentage 1 (Lctlp1) on chromosome 2 had a highly significant linkage to marker rs3723406 (LOD score of 4) with a support interval of 14 Mb and the DBA/1 allele being the CD8 þ T cell proportion-enhancing allele in an additive manner (Figure 2c) . Interestingly, although not significant, this genomic region was also linked to CD4 þ T cell proportion, with the peak marker D2Mit398 (LOD score of 2.8) and the FVB/N allele being the CD4 þ T cell proportion-enhancing allele (data not shown). Another QTL, Lctlp2, controlling CD8 þ T cell proportion was located on chromosome 5. It showed significant evidence of linkage to the peak marker D5Mit312 (LOD score of 3.3) and had a support interval of 8 Mb. The DBA/1 allele of the Lctlp1 was the CD8 þ T-cell proportionenhancing allele in an additive manner (Figure 2d) .
We also evaluated the association between the four novel QTLs and the CIA clinical phenotypes. Although not strongly significant, linkages to the clinical phenotypes were observed for three out of the four QTLs, including Lctlp1, Lctlp2 and Rosq1 ( Table 2 ). Alleles of Lctlp1 and Lctlp2 that suppressed CD8 þ T-cell proportion were correlated with higher scores of CIA severity and onset. The Rosq1 allele enhancing ROS production was correlated with higher CIA severity score. In this study, we tested the possibility of using AIL to identify novel QTLs. Four QTLs, namely Ciaa1, Lctlp1, Lctlp2 and Rosq1, were identified with support intervals of 8-15 Mb. Therefore, we showed that AIL provides an approach combining these two steps into one. However, the support intervals were relatively large for an AIL. This could be mainly accounted for by two reasons. First, we studied a small number of AIL progeny, with 308 mice for antibodies, 97 mice for ROS and 172 mice for T-cell proportion phenotypes. Second, the number of recombination events in this AIL is slightly lower than the ideal value. Once these two limitations are overcome, the QTL could be precisely localized into a genomic region small enough for direct candidate gene studies. Therefore, we suggest that AIL should be applied for QTL identification, especially for traits that can be easily tested, such as spontaneous diseases. Interestingly, the two QTLs controlling lymph node CD8 þ T-cell proportions, Lctlp1 and Lctlp2, overlap with previously identified QTLs controlling peripheral CD8 þ T-cell proportions. In this study, Lctlp1 was mapped to chromosome 2 with a support interval of 14 Mb. Recently, Valdar et al. 13 used a heterogeneous stock descended from eight inbred strains for genome-wide high-resolution mapping and this genomic region was identified as controlling both CD8 þ and CD4 þ T cell proportions with CIs of 1.4 and 2.7 Mb respectively. As the DBA/1 and FVB/N strains used in our study are not among those used to generate the heterogeneous stock, our result confirms their finding and adds more information on the QTL allele distribution among inbred strains. Another QTL controlling lymph node CD8 þ T cell proportion, Lctlp2, was mapped to an 8-Mb genomic region on chromosome 5. This genomic region has been reported to be associated with peripheral CD8 þ T cell proportion by two groups. 14, 15 Therefore, both Lctlp1 and Lctlp2 overlap with previously identified QTLs, indicating that the two QTLs could be genuine.
The newly identified Ciaa1 was mapped to a 15-Mb high gene-density genomic region containing approximately 300 genes. Interestingly, the trait of Ciaa1, anticollagen II IgG2a, was also determined in the F2 progeny but Ciaa1 was not identified. Further analysis showed that close to Ciaa1 there was a small but opposing effect QTL (LOD score 2.0) controlling the IgG2a phenotype (Figure 2b) , suggesting that the effect of Ciaa1 might have been neutralized by this opposing QTL in F2 progeny. This QTL overlaps with Sle3, a susceptibility QTL of experimental lupus that is characterized by autoantibodies. 16, 17 Furthermore, the counterpart genomic region of Ciaa1 in human is located on chromosome 19q13. 3-19q13.4 , a region that is a hot spot for autoimmune diseases susceptibility in general, including rheumatoid arthritis, multiple sclerosis, insulin-dependent diabetes mellitus and systemic lupus erythematosus (SLE). [18] [19] [20] One putative candidate gene for Ciaa1 could be interleukin 4 induced protein 1, which is a key regulator of B-cell growth and expression of membrane antigens. 21 ROS plays an important role in both cell functions and human diseases. 22 In cells, ROS can be generated by enzymes such as nicotinamide adenosine dinucleotide phosphate oxidases and xanthine oxidates or non-enzymatically by redox reactive compounds. 22 Previous studies showed that ROS production was partially controlled by genetic factors. 23 We also observed a difference in ROS production between inbred mouse strains with the FVB/N producing higher ROS than the DBA/1 strain (data not shown). In this study, we identified the first QTL controlling ROS production in mice. Interestingly, the DBA/1 allele of Rosq1 is the ROS production-enhancing allele, suggesting that ROS production is controlled by multiple genes. Rosq1 was mapped into an 8-Mb low genedensity genomic region. Two candidate genes, Gprc2a-rs5 and Gprc2a-rs1, within the support interval are functionally associated with ROS production. Both Gprc2a-rs5 and Gprc2a-rs1 are calcium-sensing receptors belonging to the metabotropic glutamate family of G-protein-coupled receptors, 24 which control the level of ROS production. 25 We also observed the sex effect on ROS products. Males produce more ROS than females, suggesting that sex hormones play a role in ROS generation. In addition, the effect of Rosq1 is higher in females than in males, indicating that the sex effect might act through regulating the genes involved in ROS generation.
Three CIA immune response QTLs, Lctlp1, Lctlp2 and Rosq1, showed linkage to CIA clinical phenotypes, suggesting that genes controlling CIA immune response could regulate the development of arthritis. Genes within Lctlp1 and Lctlp2 increasing the CD8 þ T-cell proportion have suppressing effects on CIA, affecting both severity and onset. This observation supports a previous report describing a protective role for CD8 þ T cells in CIA. 26 We also observed linkage between the gene controlling ROS production in neutrophile and CIA. The exact role of ROS during arthritis development is not completely understood. Depending on the sources and/or the cellular location, ROS might play different roles at different stages of arthritis. In this study, the DBA/1 ROS enhancing allele of Rosq1 correlates with CIA severity but not onset, indicating that ROS production controlled by Rosq1 play a role in the late stage of CIA.
In conclusion, we used an AIL to identify four novel QTLs with support intervals spanning genomic regions of 8-15 Mb. Thus, we have demonstrated that identifying novel primary QTLs in AIL is possible. With advanced genotyping technologies, the difficulties hampering the application of AIL for QTL identification will be solved and AIL will be a powerful approach for dissecting the genetic basis of quantitative traits. Our future studies will be carried out using two approaches. The first is generating congenic strains for confirming the QTLs and consequent positional cloning. The second approach is to study candidate genes within the relatively small CIs of the QTLs. In case of QTLs identified in multiple crosses or multiple species, in silico approaches will be performed to help the selection of candidate genes. The functional analysis of potential polymorphic candidate genes will be performed both in vivo and in vitro.
Materials and methods

Mice
The AIL mice were progeny of DBA/1J and FVB/N mouse strains. Both were originally obtained from the Identification of QTLs using AIL X Yu et al Jackson Laboratory (Bar Harbor, ME, USA) and were housed at the animal facility of the University of Rostock. From generation 2, random breeding of 10 males and 20 females, consistently avoiding brother-sister mating, produced all subsequent generations until generation 10. Thereafter, 29 breeding pairs were used to produce F11 mice and 32 breeding pairs were used to produce F12 mice. Eventually, 308 (DBA/1 Â FVB/N) F 11/12 AIL mice were used for the experiment. All procedures and assays were preapproved by the state's animal care committee.
Phenotype measurements AIL mice were immunized at 8-12 weeks of age at the base of the tail with 125 mg of bovine collagen II (Chondrex, Inc., Washington, USA) dissolved in 50 ml of 0.1 M acetic acid and mixed with an equal volume (50 ml) of complete Freund's Adjuvant (CFA) incomplete Freund's Adjuvant (IFA) with 4 mg/ml Mycobacterium tuberculosis; DIFCO Laboratories, Detroit, MI, USA). Sera were prepared from blood taken from 308 mice (122 F 11 and 206 F 12 ) on day 35 after immunization and used for the determination of IgG1 and IgG2a antibodies to type II collagen. CD4 þ and CD8 þ T cells were determined in lymph nodes from 97 (DBA/1 Â FVB/N) F 12 AIL mice on day 95 after immunization by FACS. The methods of measuring both antibodies and T-cell subsets were described in detail earlier.
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To determine the ROS production, we used a modified version of a previously described oxidative burst activity flow cytometry assay. 27 Briefly, 50 ml blood from 172 (DBA/1 Â FVB/N) F 12 AIL mice were lysed with 1000 ml erythrocyte lysis buffer for 10 min at room temperature and cells were resuspended in RPMI 1640 medium without fetal calf serum. Approximately 50 000 cells were incubated with 1 mM dihydrorhodamine 123 at 371C for 5 min and then activated with 10 À7 M phorbol 12-myristate 13-acetate (PMA) for additional 20 min. Cells were washed with 500 ml FACS buffer two times and incubated with phycoerythrin-conjugated anti-CD4 and anti-Gr-1 antibodies for 15 min. Samples were washed two times and the ROS production level defined as the fluorescent signal of rhodamine-123 was measured by flow cytometry.
Markers and genotyping
Four chromosomes of 308 AIL mice were genotyped with informative markers with a maximum intermarker distance of 10 Mb. Marker density was increased in the genomic intervals with the QTLs of interest. A total number of 107 informative markers (98 microsatellite markers and nine single nucleotide polymorphism markers) covering chromosome 2 (31 markers), chromosome 5 (28 markers), chromosome 7 (28 markers) and chromosome 10 (20 markers) were used, with an average intermarker distance of 5.5 Mb. Primers for informative markers were ordered from Metabion GmbH (PlaneggMartinsried, Germany). Genotyping of 308 AIL mice was performed on DNA extracted from tail tips by using PCR amplification as described earlier 11 or by a PCR-restriction fragment length polymorphism method.
Statistical analysis
All linkage analyses have been performed with QTX Map manager software B20. 28 The genetic positions of the loci were obtained from Ensembl (http://www. ensembl.org). Collagen-specific antibodies, T-cell subsets and ROS production were taken as phenotypes. The significance threshold values determined by permutation tests (n ¼ 1000). Lander and Botstein 29 defined the 95% CI as the location of each QTL as the distance between points on each side of the QTL peak at which the LOD score drops by one. However, simulation studies showed that this may underestimate the CIs under some circumstances. 30 Therefore, in this study, we defined the 95% CI as a drop of 1.5 in the LOD score.
